The failure of the pharmaceutical industry to produce drugs for common chronic diseases, emerging diseases, and the potential threats of bioterrorism or the spread of tropical diseases contrasts sharply with the industry's output of lifestyle and "me-too" drugs. In this paper we review the decision-making process that resulted in our current portfolio of medicines and offer several alternatives to better align business incentives with medical need.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1377/hlthaff.23.1.23 | DOI Listing |
Publication Analysis
Top Keywords
medicine cabinet
4
cabinet what's
4
what's change
4
change contents?
4
contents? failure
4
failure pharmaceutical
4
pharmaceutical industry
4
industry produce
4
produce drugs
4
drugs common
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!